CNTA
Price
$16.63
Change
-$0.12 (-0.72%)
Updated
Feb 21 closing price
Capitalization
2.19B
33 days until earnings call
CVKD
Price
$19.89
Change
+$0.66 (+3.43%)
Updated
Feb 21 closing price
Capitalization
35.45M
23 days until earnings call
Ad is loading...

CNTA vs CVKD

Header iconCNTA vs CVKD Comparison
Open Charts CNTA vs CVKDBanner chart's image
Centessa Pharmaceuticals
Price$16.63
Change-$0.12 (-0.72%)
Volume$755.95K
Capitalization2.19B
Cadrenal Therapeutics
Price$19.89
Change+$0.66 (+3.43%)
Volume$43.61K
Capitalization35.45M
CNTA vs CVKD Comparison Chart
Loading...
CNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CVKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNTA vs. CVKD commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTA is a Hold and CVKD is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (CNTA: $16.63 vs. CVKD: $19.89)
Brand notoriety: CNTA and CVKD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTA: 105% vs. CVKD: 80%
Market capitalization -- CNTA: $2.19B vs. CVKD: $35.45M
CNTA [@Biotechnology] is valued at $2.19B. CVKD’s [@Biotechnology] market capitalization is $35.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $369.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTA’s FA Score shows that 0 FA rating(s) are green whileCVKD’s FA Score has 0 green FA rating(s).

  • CNTA’s FA Score: 0 green, 5 red.
  • CVKD’s FA Score: 0 green, 5 red.
According to our system of comparison, both CNTA and CVKD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTA’s TA Score shows that 4 TA indicator(s) are bullish while CVKD’s TA Score has 3 bullish TA indicator(s).

  • CNTA’s TA Score: 4 bullish, 6 bearish.
  • CVKD’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both CNTA and CVKD are a bad buy in the short-term.

Price Growth

CNTA (@Biotechnology) experienced а -2.58% price change this week, while CVKD (@Biotechnology) price change was +4.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

CNTA is expected to report earnings on May 19, 2025.

CVKD is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CNTA($2.19B) has a higher market cap than CVKD($35.5M). CVKD YTD gains are higher at: 37.267 vs. CNTA (-0.716). CVKD has higher annual earnings (EBITDA): -7.61M vs. CNTA (-147.19M). CNTA has more cash in the bank: 518M vs. CVKD (4.36M). CVKD has less debt than CNTA: CVKD (2.23K) vs CNTA (84.7M). CNTA has higher revenues than CVKD: CNTA (6.85M) vs CVKD (0).
CNTACVKDCNTA / CVKD
Capitalization2.19B35.5M6,177%
EBITDA-147.19M-7.61M1,935%
Gain YTD-0.71637.267-2%
P/E RatioN/AN/A-
Revenue6.85M0-
Total Cash518M4.36M11,870%
Total Debt84.7M2.23K3,794,803%
TECHNICAL ANALYSIS
Technical Analysis
CNTACVKD
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 16 days ago
81%
Bullish Trend 11 days ago
88%
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 3 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Ad is loading...
CNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CVKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MIOFX26.94N/A
N/A
Marsico International Opportunities
CIOAX17.42N/A
N/A
Calvert International Opportunities A
EILGX18.66N/A
N/A
Eaton Vance Atlanta Capital Focused Gr I
CDDYX35.32-0.34
-0.95%
Columbia Dividend Income Inst3
JLPZX17.43-0.37
-2.08%
JPMorgan US Large Cap Core Plus R2

CNTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNTA has been loosely correlated with VCYT. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CNTA jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTA
1D Price
Change %
CNTA100%
-0.72%
VCYT - CNTA
37%
Loosely correlated
-4.56%
IMNM - CNTA
35%
Loosely correlated
-5.84%
XENE - CNTA
35%
Loosely correlated
+0.89%
FULC - CNTA
34%
Loosely correlated
N/A
KYMR - CNTA
32%
Poorly correlated
-1.63%
More

CVKD and

Correlation & Price change

A.I.dvisor tells us that CVKD and GDTC have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CVKD and GDTC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVKD
1D Price
Change %
CVKD100%
+3.46%
GDTC - CVKD
29%
Poorly correlated
+1.82%
GOSS - CVKD
22%
Poorly correlated
-8.50%
MRKR - CVKD
22%
Poorly correlated
-3.68%
VINC - CVKD
22%
Poorly correlated
-0.80%
CNTA - CVKD
22%
Poorly correlated
-0.72%
More